These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23816430)

  • 1. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
    Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
    Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
    Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
    Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
    Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
    J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
    Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
    J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminosugars: A host-targeted approach to combat Flaviviridae infections.
    Evans DeWald L; Starr C; Butters T; Treston A; Warfield KL
    Antiviral Res; 2020 Dec; 184():104881. PubMed ID: 32768411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
    Miller JL; Tyrrell BE; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
    Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2006 Apr; 87(Pt 4):861-871. PubMed ID: 16528036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
    Chang J; Schul W; Butters TD; Yip A; Liu B; Goh A; Lakshminarayana SB; Alonzi D; Reinkensmeier G; Pan X; Qu X; Weidner JM; Wang L; Yu W; Borune N; Kinch MA; Rayahin JE; Moriarty R; Xu X; Shi PY; Guo JT; Block TM
    Antiviral Res; 2011 Jan; 89(1):26-34. PubMed ID: 21073903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
    Warfield KL; Alonzi DS; Hill JC; Caputo AT; Roversi P; Kiappes JL; Sheets N; Duchars M; Dwek RA; Biggins J; Barnard D; Shresta S; Treston AM; Zitzmann N
    J Med Chem; 2020 Apr; 63(8):4205-4214. PubMed ID: 32227946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
    Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses.
    Chang J; Wang L; Ma D; Qu X; Guo H; Xu X; Mason PM; Bourne N; Moriarty R; Gu B; Guo JT; Block TM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1501-8. PubMed ID: 19223639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-glucosidase inhibitors as potential broad based anti-viral agents.
    Mehta A; Zitzmann N; Rudd PM; Block TM; Dwek RA
    FEBS Lett; 1998 Jun; 430(1-2):17-22. PubMed ID: 9678587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.